Johnson & Johnson sees $1B impact in 2013 from health care law Says 2013 guidance reflects the assumption of the implementation of the medical device excise tax, which has an incremental negative impact to earnings per share of 5c and will be recorded in cost of goods sold. Sees the overall impact to Johnson & Johnson of the provisions of the Affordable Care Act in 2013 estimated to be the equivalent of $1B of cost, or approximately 25c of earnings per share. Comments from Q4 earnings conference call.
News For JNJ From The Last 14 Days
Check below for free stories on JNJ the last two weeks.